当前位置: X-MOL 学术J. Cardiovasc. Pharmacol. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Diabetic Control Agents and Their Impact on Cardiac Surgery Patients: A Clinical Overview
Journal of Cardiovascular Pharmacology and Therapeutics ( IF 2.6 ) Pub Date : 2020-11-23 , DOI: 10.1177/1074248420963688
Parker O'Neill 1 , Marco Shiu Tsun Leung 1 , Renier A B Visser 2 , Amer Harky 3
Affiliation  

Chronic hyperglycemia is associated with poor cardiovascular surgical outcomes due to microvascular and macrovascular complications. This is a major concern as over one third of cardiovascular surgical patients have diabetes mellitus which greatly increases their risk of experiencing adverse cardiovascular events. A literature review was performed to identify articles discussing the effects of anti-diabetic medications (ADMs) on cardiovascular outcomes and surgical mortality and morbidity rates. Optimizing perioperative glucose levels remains a key factor in producing good surgical outcomes. In addition, recognizing gender differences, increasing patient satisfaction, and implementing dedicated diabetic teams all improve surgical mortality and morbidity rates in the diabetic population.



中文翻译:

糖尿病控制药物及其对心脏手术患者的影响:临床概述

由于微血管和大血管并发症,慢性高血糖与心血管手术结果不佳有关。这是一个主要问题,因为超过三分之一的心血管手术患者患有糖尿病,这大大增加了他们发生心血管不良事件的风险。进行了文献综述以找出讨论抗糖尿病药物 (ADM) 对心血管结局和手术死亡率和发病率影响的文章。优化围手术期血糖水平仍然是产生良好手术结果的关键因素。此外,认识到性别差异、提高患者满意度和建立专门的糖尿病团队都可以提高糖尿病人群的手术死亡率和发病率。

更新日期:2020-11-23
down
wechat
bug